7Baggers
 Feds Eye Partial Pretrial Ruling In Regeneron FCA Case  Law360 Fri, 03 Oct 2025 01:48:00 GMT
 Q3 Earnings Forecast for REGN Issued By Leerink Partnrs  MarketBeat Thu, 02 Oct 2025 11:55:20 GMT
 regeneron (regn) sees stock surge as core product sales rise  GuruFocus Wed, 01 Oct 2025 14:56:41 GMT
 red biotechnology market size, analysis, trends | leading  openPR.com Wed, 01 Oct 2025 12:28:52 GMT
 u.s. biologics market set to witness massive growth by 2032:  openPR.com Wed, 01 Oct 2025 09:44:19 GMT
 Regeneron: Growth Catalysts Incoming (NASDAQ:REGN)  Seeking Alpha Tue, 30 Sep 2025 20:25:35 GMT
 regeneron sues biosimilar maker over ip rights exemption  Law360 Tue, 30 Sep 2025 16:57:00 GMT
 regeneron deal clears formycon’s eylea biosimilar for late 2026  Bloomberg Law News Tue, 30 Sep 2025 16:18:00 GMT
 2 Beaten-Down Stocks to Buy and Hold for a Decade  Yahoo Finance Tue, 30 Sep 2025 11:30:00 GMT
 published on: 2025-09-29 10:34:05  newser.com Mon, 29 Sep 2025 15:34:05 GMT
 Here’s Why Regeneron Pharmaceuticals (REGN) Fell in Q2  Yahoo Finance Mon, 29 Sep 2025 14:43:14 GMT
 fda approves treatment of rare genetic disorder in children as young as 1 year old  Cardiovascular Business Mon, 29 Sep 2025 14:15:58 GMT
 FDA Approves Label Extension of REGN's Cholesterol Drug Evkeeza  Yahoo Finance Mon, 29 Sep 2025 12:28:00 GMT
 Regeneron’s Evkeeza gains FDA approval for young HoFH patients  Pharmaceutical Technology Mon, 29 Sep 2025 09:04:19 GMT
 The Best Biotech Stocks to Buy  Morningstar Mon, 29 Sep 2025 07:00:00 GMT
 1 Healthcare Stock with Exciting Potential and 2 We Ignore  TradingView Mon, 29 Sep 2025 04:36:00 GMT
 6 FDA Decisions To Watch for in Q4  BioSpace Mon, 29 Sep 2025 04:07:30 GMT
 Regeneron: Strong R&D Pipeline Drives Growth Outlook  Seeking Alpha Sat, 27 Sep 2025 13:00:32 GMT
 follicular lymphoma market to experience notable growth  openPR.com Fri, 26 Sep 2025 13:50:04 GMT
 fda expands use of regeneron's (regn) evkeeza for young children  GuruFocus Fri, 26 Sep 2025 12:09:50 GMT
 fda extends evkeeza approval to treat children as young as 1 with hofh  Investing.com India Fri, 26 Sep 2025 12:05:43 GMT
 regeneron (regn) gains fda approval for evkeeza expansion to you  GuruFocus Fri, 26 Sep 2025 11:35:12 GMT
 Regeneron wins FDA label expansion for Evkeeza (REGN:NASDAQ)  Seeking Alpha Fri, 26 Sep 2025 11:32:47 GMT
 regeneron announces u.s. fda approved evkeeza angptl3 antibody  TipRanks Fri, 26 Sep 2025 11:31:40 GMT
 u.s. vitreotamponades market generated opportunities, future  openPR.com Fri, 26 Sep 2025 10:27:18 GMT
 why regeneron (regn) shares are falling today  FinancialContent Thu, 25 Sep 2025 20:51:00 GMT
 lilly, johnson & johnson, regeneron to highlight life sciences speakers…  Supply Chain Management Review Thu, 25 Sep 2025 13:48:00 GMT
 united states basal cell carcinoma treatment market growth  openPR.com Thu, 25 Sep 2025 07:46:43 GMT
 1 safe-and-steady stock on our watchlist and 2 we question  Yahoo Finance Thu, 25 Sep 2025 04:37:30 GMT
 regeneron at bernstein forum: strategic growth & challenges  Investing.com Wed, 24 Sep 2025 18:31:21 GMT
 regeneron pharmaceuticals hits day low amid price pressure at $565.53  Markets Mojo Wed, 24 Sep 2025 10:07:58 GMT
 biotech stocks facing fda decision in october 2025  RTTNews Wed, 24 Sep 2025 02:19:00 GMT
 Why Regeneron (REGN) Stock Is Down Today  Yahoo Finance Tue, 23 Sep 2025 07:00:00 GMT
 fda delays key sanofi multiple sclerosis drug decision  Benzinga Mon, 22 Sep 2025 16:07:06 GMT
 sny & regn's dupixent receives chmp backing for urticaria in eu  Yahoo Finance Mon, 22 Sep 2025 16:03:00 GMT
 brief—regeneron's linvoseltamab demonstrates 100% overall response  The Pharma Letter Mon, 22 Sep 2025 15:17:44 GMT
 all eyes on elyea–sandoz defeats preliminary injunction  The National Law Review Mon, 22 Sep 2025 13:46:58 GMT
 sanofi (sny) advances with dupixent for skin condition in eu  GuruFocus Mon, 22 Sep 2025 09:56:49 GMT
 alvotech files pgr against regeneron high-dose aflibercept patent  MarketScreener Mon, 22 Sep 2025 08:13:13 GMT
 regeneron to pit lynozyfic against j&j’s darzalex in smoldering myeloma  insights.citeline.com Fri, 19 Sep 2025 20:17:07 GMT
 can regeneron change the paradigm in multiple myeloma — and undercut j&j?  Investor's Business Daily Fri, 19 Sep 2025 17:15:00 GMT
 regeneron pharmaceuticals inc to donate 500 doses of inmazeb to who  MarketScreener Fri, 19 Sep 2025 16:20:24 GMT
 aplastic anemia market analysis: epidemiology insights,  openPR.com Fri, 19 Sep 2025 11:58:02 GMT
 regeneron (regn) supports global health with inmazeb donation  GuruFocus Fri, 19 Sep 2025 11:56:17 GMT
 myopic macular degeneration market analysis: epidemiology  openPR.com Fri, 19 Sep 2025 11:56:04 GMT
 ophthalmic drugs market to surpass $68.7 billion by 2034,  openPR.com Fri, 19 Sep 2025 06:50:24 GMT
 1 cash-heavy stock to research further and 2 we brush off  TradingView Fri, 19 Sep 2025 04:45:58 GMT
 regeneron drug on track to be second fop treatment  pharmaphorum Thu, 18 Sep 2025 12:42:08 GMT
 regeneron posts positive phase iii trial of garetosmab  The Pharma Letter Thu, 18 Sep 2025 12:16:56 GMT
 regeneron tees up us submission for garetosmab after phase iii fop win  FirstWord Pharma Wed, 17 Sep 2025 22:22:09 GMT
 regeneron’s garetosmab may become second drug for rare bone disease fop  insights.citeline.com Wed, 17 Sep 2025 20:59:32 GMT
 regeneron (regn) rises amid positive obesity treatment study  GuruFocus Wed, 17 Sep 2025 18:57:28 GMT
 regeneron, elf beauty, eli lilly  TradingView Wed, 17 Sep 2025 17:59:13 GMT
 oruka therapeutics, regeneron, natgas companies  TradingView Wed, 17 Sep 2025 15:47:48 GMT
 ‘prolific’ regeneron won’t stop with phase iii fop data drop  BioWorld MedTech Wed, 17 Sep 2025 15:00:00 GMT
 birch allergy market trends point to steady growth ahead by 2034,  openPR.com Wed, 17 Sep 2025 13:52:04 GMT
 oruka therapeutics brings back the ‘wall-crossed’ pipe  statnews.com Wed, 17 Sep 2025 13:42:38 GMT
 regeneron's garetosmab hits main endpoint in phase 3 study  MarketScreener Wed, 17 Sep 2025 11:39:11 GMT
 regeneron posts trial win for connective disorder therapy  Seeking Alpha Wed, 17 Sep 2025 11:34:33 GMT
 Regeneron Pharmaceuticals, Inc. $REGN Shares Bought by Swedbank AB  MarketBeat Wed, 17 Sep 2025 07:00:00 GMT
 pozelimab and cemdisiran combo holds potential in mg market  The Pharma Letter Tue, 16 Sep 2025 09:53:05 GMT

Regeneron Pharmaceuticals, Inc
(NASDAQ:REGN) 

REGN stock logo

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovas...

Founded: 1988
Full Time Employees: 8,314
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends